Biotech2
Anthropic Acquires Coefficient Bio for $400M as AI Enters Drug Discovery
Anthropic's $400M acquisition of AI biotech startup Coefficient Bio signals a major shift - AI labs are no longer just building models, they're targeting entire industries. Here's what it means for the future of life sciences.
Anthropic Acquires AI Biotech Startup Coefficient Bio for $400M
Anthropic is pushing beyond general-purpose AI with its $400M acquisition of Coefficient Bio, a startup applying AI to drug discovery and clinical workflows. The move signals AI's expansion into high-stakes scientific domains.